Spine Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain byTim AllenDecember 2, 2025
Recon Orthopedic Surgeon Tomas Pevny, MD, of Valley View, Is the First in the Roaring Fork Valley to Offer iovera°, a New Option to Manage Knee Pain byJosh SandbergFebruary 13, 2024
Financial Top Stories Myoscience Announces Agreement to be Acquired by Pacira for up to $220 Million byJosh SandbergMarch 5, 2019
Recon OSN Interview with David Derminio – Executive Vice President Commercialization at Myoscience byJosh SandbergNovember 15, 2018
